RVL Pharmaceuticals PLC (FRA:O1P)
€ 0.003 0 (0%) Market Cap: 1.65 Mil Enterprise Value: 38.48 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Osmotica Pharmaceuticals PLC at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 09, 2021 / 02:45PM GMT
Release Date Price: €2.94
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

Good morning, everyone. My name is Balaji Prasad, and I lead the specialty pharma coverage for Barclays. Thank you for dialing into the Barclays Global Healthcare Conference, still in a virtual format.

We have with us today the management team from Osmotica, Brian Markison and Andy Einhorn. So I -- the format will be a presentation from the team.

And Brian and Andy, I'll let you guys take over. Thank you.

Brian and Andy, I think you're on mute.

Brian A. Markison
Osmotica Pharmaceuticals plc - Chairman, President & CEO

Here we go. All right. How are you? Good?

Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

I'm good. Yes.

Brian A. Markison
Osmotica Pharmaceuticals plc - Chairman, President & CEO

Very good. All right. Good morning, and good afternoon, everybody. This is Brian Markison. And with me today is Andrew Einhorn, our CFO; and JD Schaub, Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot